Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Difluprednate in Dry Eye Disease
NCT01276223Phase 2Completed
- Sponsor
- Alcon Inc.
- Start
- Feb 2011
- Primary completion
- Jan 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of difluprednate in dry eye disease (DED), sponsored by Alcon Inc.. Started Feb 2011; status: completed.
02
Drugs
difluprednate
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT01276223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01276223.